Should we stop anti-thrombotic agents prior to vitrectomy?

Should we stop anti-thrombotic agents prior to vitrectomy? Graefe's Archive for Clinical and Experimental Ophthalmology (2018) 256:459–460 https://doi.org/10.1007/s00417-017-3898-0 EDITORIAL (BY INVITATION) 1 2 3 David Yorston & David Wong & Antonia Joussen Received: 29 December 2017 /Accepted: 29 December 2017 / Published online: 17 January 2018 Springer-Verlag GmbH Germany, part of Springer Nature 2018 All retinal surgeons are occasionally faced with the dilemma haemorrhagic complications. Anecdotally, we are aware of of operating on a patient who is taking anti-thrombotic med- reports of severe intra-operative haemorrhage associated with ication. Although there is clear guidance that anti-thrombotics anti-platelet agents—particularly clopidogrel [1]. pose little risk in cataract surgery, the situation is more con- The risk of haemorrhage is likely to be affected by the fused when it comes to vitreoretinal surgery [1], and there are indication for vitrectomy. We would expect a lower risk in surgery for macular hole or epiretinal membrane, compared wide variations in practice. Vitrectomies are more likely to be affected by haemorrhagic complications than clear cornea to delamination for proliferative diabetic retinopathy [2]. phacoemulsification, and the consequences of bleeding into Bleeding complications occurred in 17.6% of eyes undergoing the eye during a vitrectomy can be very serious. The paper by surgery for complications of proliferative diabetic http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Graefe's Archive for Clinical and Experimental Ophthalmology Springer Journals

Should we stop anti-thrombotic agents prior to vitrectomy?

Loading next page...
 
/lp/springer_journal/should-we-stop-anti-thrombotic-agents-prior-to-vitrectomy-qHv8kDSIZE
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2018 by Springer-Verlag GmbH Germany, part of Springer Nature
Subject
Medicine & Public Health; Ophthalmology
ISSN
0721-832X
eISSN
1435-702X
D.O.I.
10.1007/s00417-017-3898-0
Publisher site
See Article on Publisher Site

Abstract

Graefe's Archive for Clinical and Experimental Ophthalmology (2018) 256:459–460 https://doi.org/10.1007/s00417-017-3898-0 EDITORIAL (BY INVITATION) 1 2 3 David Yorston & David Wong & Antonia Joussen Received: 29 December 2017 /Accepted: 29 December 2017 / Published online: 17 January 2018 Springer-Verlag GmbH Germany, part of Springer Nature 2018 All retinal surgeons are occasionally faced with the dilemma haemorrhagic complications. Anecdotally, we are aware of of operating on a patient who is taking anti-thrombotic med- reports of severe intra-operative haemorrhage associated with ication. Although there is clear guidance that anti-thrombotics anti-platelet agents—particularly clopidogrel [1]. pose little risk in cataract surgery, the situation is more con- The risk of haemorrhage is likely to be affected by the fused when it comes to vitreoretinal surgery [1], and there are indication for vitrectomy. We would expect a lower risk in surgery for macular hole or epiretinal membrane, compared wide variations in practice. Vitrectomies are more likely to be affected by haemorrhagic complications than clear cornea to delamination for proliferative diabetic retinopathy [2]. phacoemulsification, and the consequences of bleeding into Bleeding complications occurred in 17.6% of eyes undergoing the eye during a vitrectomy can be very serious. The paper by surgery for complications of proliferative diabetic

Journal

Graefe's Archive for Clinical and Experimental OphthalmologySpringer Journals

Published: Jan 17, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off